Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Details)

v3.19.1
SHARE BASED COMPENSATION (Details) - Restricted Stock
3 Months Ended
Mar. 31, 2019
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Non-vested, beginning balance, shares | shares 513,766
Vested, shares | shares (242,850)
Forfeited, shares | shares 0
Non-vested, ending balance, shares | shares 666,460
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Non-vested, beginning balance, Weighted Average Grant Price (USD per share) | $ / shares $ 10.28
Vested, Weighted Average Grant Price (USD per share) | $ / shares 10.36
Forfeited, Weighted Average Grant Price (USD per share) | $ / shares 0.00
Non-vested, ending balance, Weighted Average Grant Price (USD per share) | $ / shares $ 10.29
Non-employee directors  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 34,488
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 10.35
Employees  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 361,056
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 10.35